With the future of the EU HTA Regulation in question, Niklas Hedberg, Chair of the EUnetHTA Executive Board, discusses what’s needed to get the HTA Proposal back on track. Recorded at the HTAi conference in Köln, Niklas also expresses his opinions on the state of the OMP legislation from the standpoint of both EUnetHTA and his home HTA in Sweden, and does so incorporating the discussions around the orphan legislation at the conference. Niklas Hedberg is the Chief Pharmacist of the Swedish Pharmaceutical Benefits Agency (TLV) and a frequent presenter at leading conferences such as DIA and ISPOR. He is seen as one of Europe’s young visionaries, working to develop new approaches to evaluating medicines in the member states while also improving access for patients.See omnystudio.com/listener for privacy information.